Company
United StatesPublic company, NYSE: SRSpire Inc (NYSE: SR), San Francisco, CA – FDA Inspections
Inspection records and compliance data for Spire Inc in San Francisco, California. 1 FDA inspection on record, last inspected January 29, 2025. Publicly traded as NYSE: SR.
Company Profile
This profile covers Spire Inc based in San Francisco, California, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected January 29, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 29, 2025 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1231537 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Spire Inc
Stock ticker
SR
Exchange
NYSE
Share price
$89.34
Market cap
$5.3B
Price as of
November 6, 2026
FEI Number
3011166598
Address
555 De Haro St Ste 300, San Francisco, California 94107, United States
Country
United States
ID: 2fa0a306-1037-476f-93b5-a976fac6038e